DOI:

The latest news from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)

William Wijns*, President EAPCI

As a reader of EuroIntervention Journal, percutaneous cardiovascular intervention must be your primary interest. If so, please take a few moments to read the following update news from your association, the European Association for Percutaneous Cardiovascular Interventions, known as the EAPCI.

EAPCI was formally launched at the World Congress 2006 in Barcelona as a registered branch of the European Society of cardiology. We share the ESC mission, albeit focused on our field of activity:

“To reduce the burden of cardiovascular disease in Europe

through Percutaneous Cardiovascular Interventions”

and the KEYWORDS that govern our action are:

Synergy

Focus

and Credibility.

Even though so recently born, EAPCI is already able to offer you important assets, represented by the heritage of its proud parents (EuroPCR and Working Group 10):

– EuroPCR Course, to take place this year for the first time in Barcelona, on the 22nd-25th May 2007,

– EuroPCRonline.com, featuring outstanding educational content, and the EAPCI website accessible on ESCardio.org,

– Euro Heart Survey and Registry,

– A comprehensive Education-Training-Accreditation programme,

– and not to forget, EuroIntervention Journal itself.

For EAPCI, strengths and opportunities are many. The coalition formed by the EuroPCR team – representing nearly two decades of commitment to education and teaching – along with the European Society of Cardiology – “the” representative cardiovascular medical scientific society in Europe and beyond – is a unique model. The blend of both cultures will materialise strong synergies as we consolidate our current assets and explore new activities.

At a moment where our field is experiencing another wave of expansion, leadership will be needed more than ever. To this end, EAPCI will rely entirely on a close collaboration with the national Working Groups, Societies or other bodies representing interventional communities throughout Europe, as the building blocks of our action. EAPCI can only be successful when governed by a “bottom up” relationship with its constituency.

At the beginning of the three-year term of this Board, many new initiatives are being considered, but at this present time please consider what we already have up and running right now. EAPCI leadership is structured in 8 Committees, each having a well defined mission that will be further delineated on our website and future newsletters: Communication, Euro Heart Survey, Scientific Initiatives, National Membership, Education, Fellowship, Accreditation and Clinical Initiatives. Through your national representatives, you will be asked to join and engage in these various committees, making EAPCI an essential component of your professional life in the years to come.

EAPCI Board 2006-2009.

Rows from left to right and from bottom to top,

– Marc van Sambeek, Keren Deront (EAPCI Office at ESC), Carlo Di Mario (President-Elect),

– Antoine Lafont, Sigmund Silber, Darius Dudek (Secretary),

– Martyn Thomas, Andreas Baumbach, Jean Marco, Jan-Erik Nordrehaug,

– Alberto Cremonesi, Franz Eberli, Horst Sievert (Treasurer), Franz Weidinger, William Wijns (President),

– Bernard Chevalier, Ran Kornowski, Jean Fajadet, Alec Vahanian, Alan Howard (CEO ESC).

Missing on the picture are Sally Vincent (EuroPCR office), Marc Doncieux (CEO Europa) and Patrick Serruys.

Volume 2 Number 4
Feb 20, 2007
Volume 2 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00061 Mar 3, 2025
CIED and tricuspid regurgitation – a LEADing problem?
Andreas M et al
free

Editorial

10.4244/EIJ-E-25-00006 Mar 3, 2025
Tricuspid annuloplasty: a piece of the puzzle or the whole picture?
Nickenig G and Vogelhuber J
free

Editorial

10.4244/EIJ-E-24-00074 Mar 3, 2025
Access site closure after TAVI: invincible sutures
Abdel-Wahab M and Dumpies O
free

Flashlight

10.4244/EIJ-D-24-00816 Mar 3, 2025
Double mitral and tricuspid transcatheter valve replacement
Leurent G et al

Original Research

10.4244/EIJ-D-23-01033 Mar 3, 2025
Outcomes of tricuspid transcatheter edge-to-edge repair in subjects with endocardial leads
Goebel B et al

Original Research

10.4244/EIJ-D-24-00120 Mar 3, 2025
A propensity-matched comparison of plug- versus suture-based vascular closure after TAVI
Grundmann D et al

Research Correspondence

10.4244/EIJ-D-24-00741 Mar 3, 2025
Balloon-expandable SAPIEN 3 Ultra valve in intermediate sizing zones: insights from the OPERA-TAVI registry
Costa G et al
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
54

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
33.8

Translational research

10.4244/EIJ-D-23-00308 Nov 17, 2023
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion
Meier D et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
22.55

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00774 Oct 19, 2018
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease
Azzalini L et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved